Search research articles
Contact Us
Filters
Showing results (141-150 of 179) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2023
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer
Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, et al.
Breast Cancer Research and Treatment
|
November 8, 2017
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer
Mothaffar F Rimawi, Carmine De Angelis, Alejandro Contreras, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
Cynthia X Ma, Ron Bose, Feng Gao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 26, 2010
Breast cancer: noninvasive and special situations
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 25, 2008
Non-Hodgkin's lymphomas
Andrew D Zelenetz, Ranjana H Advani, John C Byrd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2011
Invasive breast cancer
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2010
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas
Andrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Cancer Cell
|
May 5, 2023
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 179) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2023
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer
Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, et al.
Breast Cancer Research and Treatment
|
November 8, 2017
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer
Mothaffar F Rimawi, Carmine De Angelis, Alejandro Contreras, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
Cynthia X Ma, Ron Bose, Feng Gao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 26, 2010
Breast cancer: noninvasive and special situations
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 25, 2008
Non-Hodgkin's lymphomas
Andrew D Zelenetz, Ranjana H Advani, John C Byrd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2011
Invasive breast cancer
Robert W Carlson, D Craig Allred, Benjamin O Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2010
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas
Andrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Cancer Cell
|
May 5, 2023
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, et al.
Page
of 18